argenx
argenx is an antibody therapies founded in 2008 by Tim Van Hauwermeiren, Hans J. W. de Haard and Torsten Dreier.
$2.0b
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti* Va* Ha********** | - | - | |
| Ha** J. W. de Ha*** | - | - | |
| To***** Dr**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti* Va* Ha********** | - | - | |
| Di** Be******* | - | - | - |
| We**** La******* |
|
- | |
| Ka** Gu**** | - | - | - |
| Ke*** Wo*** | - | - | |
| Wi* Pa*** | - | - | |
| Ar*** Le**** | - | - | |
| An**** Wi** | - | - | |
| Ma** Sc******* | - | - | |
| Pe*** Ve******* | - | - | - |
| Do* de******* | - | - | |
| Pa**** M. Kl*** | - | - | |
| A.** Ro******* | - | - | - |
| Ja*** M. Da** | - | - |
Industries
argenx is active in the following industries: